在人体血和尿液中量化口服的氏丁硫酸盐寡糖
Hiroko Mizuta1, Shota Kawahara1, Naonobu Tsutsumi1
1Fine Chemical Lab., Marukyou Bio Foods Co., Ltd., 2-1-40, Nishi-Miyanosawa 4-jo, Teine, Sapporo, Hokkaido, 006-0004, 42-1-40 Nishi-Miyanosawa, Teine, Sapporo, Hokkaido 006-0004, Japan.
Glycobiology
|July 13, 2023
概括
与高分子量形式相比,低分子量二丁硫酸寡糖在人类中显示出更好的吸收和生物利用性. 这一发现表明,可以改进氏丁硫酸盐的口服施用策略.
科学领域:
- 生物化学 生物化学
- 药理动力学 药理动力学
- 胃肠病学 胃肠病学
背景情况:
- 氏丁硫酸盐通常用于膝关节骨关节炎,但由于其高分子量,其口服吸收和生物可用性受到争议.
- 它的生物活性包括抗炎,免疫调节,抗氧化和抗瘤特性.
研究的目的:
- 评估低分子量二丁硫酸盐寡糖在人类的口服吸收和生物可用性.
- 为了比较口服后的不同分子量氏丁硫酸盐的吸收.
主要方法:
- 四种具有不同分子重量的氏硫酸盐 (氏硫酸盐四糖化物,CSOS-1,CSOS-2,HMWCS) 被口服给人类.
- 血和尿液中的外源性氏丁硫酸盐水平使用带有光探测器的高性能液体染色学量化.
- 作为评估肠道吸收的参数,使用了外源性氏丁硫酸盐在尿液中的分泌.
主要成果:
- 在24小时内,外源性氏丁硫酸盐在尿液中的分泌量在氏丁硫酸盐寡糖群中明显高于高分子量氏丁硫酸盐组.
- 尿中二丁硫酸寡糖的分子量分布表明,较低分子量部分的吸收效率更高.
- 胆素硫酸四糖糖的血和尿液度模式相似,这表明尿液分泌反映了血液中的度.
结论:
- 低分子量二丁硫酸盐通过人类的消化道更有效地被吸收.
- 这些发现表明,氏丁硫酸盐寡糖可能为口服提供更好的生物可用性.
相关概念视频
Transcellular Transport of Solutes
Transcellular transport of solutes is the movement of substances like monosaccharides and amino acids through polarized cells. This transport mechanism is primarily seen in epithelial and endothelial cells aided by membrane transport proteins such as channels and transporters. The tight junctions between these cells confine the membrane proteins to the two sides of the cell. The epithelial cells have distinct apical and basolateral domains. In contrast, the endothelial cells show the luminal...
Roles of Electrolytes: Chloride and Bicarbonate
Chloride ions contribute to the osmotic pressure gradient distinguishing the intracellular fluid (ICF) from the extracellular fluid (ECF). They counterbalance positively charged ions in the ECF and ensure its electrochemical stability. The renal system's process of chloride absorption and release generally mirrors that of sodium ions.
Conditions such as hypochloremia can arise from insufficient chloride reabsorption by the kidneys, often compounded by extended bouts of diarrhea, vomiting, or...
Conditions such as hypochloremia can arise from insufficient chloride reabsorption by the kidneys, often compounded by extended bouts of diarrhea, vomiting, or...
Oral Hypoglycemic Agents: Biguanides and Glitazones
Biguanides, particularly metformin (Glucophage), are insulin sensitizers that enhance glucose uptake, thereby reducing insulin resistance. Unlike sulfonylureas, metformin doesn't prompt insulin secretion, which helps to curb hypoglycemia risk. Metformin is beneficial in treating conditions like polycystic ovary syndrome due to its insulin-resistance reduction capability. The drug's primary action involves curtailing hepatic gluconeogenesis, a significant contributor to high blood glucose levels...
Oral Hypoglycemic Agents: α-Glucosidase Inhibitors
α-glucosidase inhibitors, including acarbose (Precose), miglitol (Glyset), and voglibose (Voglib) (primarily available in Asia), are drugs that control blood sugar levels by delaying the digestion of starch and disaccharides. They achieve this by inhibiting α-glucosidase enzymes in the intestine, which slow the absorption of carbohydrates in the intestine, which in turn leads to a prolonged release of the glucoregulatory hormone GLP-1 from intestinal L-cells.
Acarbose and miglitol are typically...
Acarbose and miglitol are typically...
Physiology of the Genitourinary System III: Urine Concentration and Dilution
The kidneys concentrate or dilute urine to maintain water and electrolyte balance. Nephrons, particularly the loop of Henle, play a crucial role in this process through the countercurrent multiplication system. This system establishes a high osmolarity in the renal medulla, which is essential for water reabsorption. In the loop of Henle’s descending limb, water is reabsorbed into the surrounding medulla due to its permeability to water. In contrast, the ascending limb actively transports...
Hypoglycemia
Hypoglycemia is a blood glucose level below 70 mg/dL. It commonly occurs in individuals using insulin or insulin-secreting drugs, but may also arise in non-diabetic conditions. People with type 1 diabetes are at the highest risk because they depend on exogenous insulin. People with type 2 diabetes are also at risk, especially when treated with insulin or medications such as sulfonylureas, which increase insulin release regardless of blood glucose levels. It develops when insulin levels exceed...


